$VRTX, Long, TP>25% NASDAQ:VRTX , Long, TP>25%
Fundamentally the stock is good.
Choose an entry point and do not forget about a protective order if you are trading with leverage.
Don't risk it if you're not sure.
Good luck to everyone.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−36.51 MXN
61.48 B MXN
167.12 B MXN
256.90 M
About Vertex Pharmaceuticals Incorporated
Sector
CEO
Reshma Kewalramani
Headquarters
Boston
Website
Founded
1989
FIGI
BBG004PVSS21
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
VRTX"A quick trade for traders based on a classic, well-known pattern: Symmetrical Triangle. Entry at $500, stop loss at $460. First target between $527.5 _ $535. Second target between $544 _ $549."
VRTXThe VRTX stock has broken the ascending channel and successfully retested it. It is now ready to be sold with a first target between $404.60 and $403, and a second target of $375.50. The stop loss is at $500.
VRTX Vertex Pharmaceuticals Options Ahead of EarningsAnalyzing the options chain and the chart patterns of VRTX Vertex Pharmaceuticals prior to the earnings report this week,
I would consider purchasing the 472.5usd strike price Puts with
an expiration date of 2024-11-8,
for a premium of approximately $14.00.
If these options prove to be profitable pr
Vertex Pharmaceuticals (VRTX) | Chart & Forecast SummaryRight Here You Can See Vertex Pharmaceuticals Incorporated (VRTX) Registered As (VRTX) On The New York Stock Exchange, Vertex Pharmaceuticals Incorporated Is An American Biopharmaceutical Company Based In Boston, Massachusetts.
The Following Chart & Forecast Summary On Vertex Pharmaceuticals Incorp
VRTX Bull FlagVRTX is approaching the top end of bull flag on the 4hr. A break could lead to a move back up to ATH and beyond. The flag pole on this one is pretty big so if going on that projection it could see $600 if it does get continuation above.
A bearish scenario would be a rejection here at the top end or
Buy Vertex PharmaceuticalsShort Term Trading Advice by Naranj Capital
Buy Vertex Pharmaceuticals
● Buy Range- 475 - 480
● Target- 500 - 505
● StopLoss- 460
● Potential Return- 5-6%
● Duration- 12-14 Trading Days
VRTX upside?Beautiful bullflag breaking on the hourly and higher time frames, Targeting previous highs
Eyes on VRTXVRTX bouncing nicely off recent lows and has broken downtrend. Final confirmation would be a daily close over 421.50. Looking to enter a starter position and will add on a retest of the daily 48.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where VRTX is featured.
Frequently Asked Questions
The current price of VRTX is 8,107.40 MXN — it has increased by 1.34% in the past 24 hours. Watch VERTEX PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange VERTEX PHARMACEUTICAL stocks are traded under the ticker VRTX.
VRTX stock has fallen by −14.39% compared to the previous week, the month change is a −11.08% fall, over the last year VERTEX PHARMACEUTICAL has showed a 15.32% increase.
We've gathered analysts' opinions on VERTEX PHARMACEUTICAL future price: according to them, VRTX price has a max estimate of 12,238.26 MXN and a min estimate of 6,607.03 MXN. Watch VRTX chart and read a more detailed VERTEX PHARMACEUTICAL stock forecast: see what analysts think of VERTEX PHARMACEUTICAL and suggest that you do with its stocks.
VRTX reached its all-time high on Nov 11, 2024 with the price of 10,477.52 MXN, and its all-time low was 808.03 MXN and was reached on Apr 14, 2014. View more price dynamics on VRTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VRTX stock is 1.32% volatile and has beta coefficient of 1.28. Track VERTEX PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is VERTEX PHARMACEUTICAL there?
Today VERTEX PHARMACEUTICAL has the market capitalization of 2.08 T, it has increased by 0.94% over the last week.
Yes, you can track VERTEX PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
VERTEX PHARMACEUTICAL is going to release the next earnings report on Feb 11, 2025. Keep track of upcoming events with our Earnings Calendar.
VRTX earnings for the last quarter are 86.30 MXN per share, whereas the estimation was 80.35 MXN resulting in a 7.41% surprise. The estimated earnings for the next quarter are 82.39 MXN per share. See more details about VERTEX PHARMACEUTICAL earnings.
VERTEX PHARMACEUTICAL revenue for the last quarter amounts to 54.62 B MXN, despite the estimated figure of 52.91 B MXN. In the next quarter, revenue is expected to reach 56.62 B MXN.
VRTX net income for the last quarter is 20.60 B MXN, while the quarter before that showed −65.91 B MXN of net income which accounts for 131.25% change. Track more VERTEX PHARMACEUTICAL financial stats to get the full picture.
No, VRTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 5.40 K employees. See our rating of the largest employees — is VERTEX PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VERTEX PHARMACEUTICAL EBITDA is −1.74 B MXN, and current EBITDA margin is 45.32%. See more stats in VERTEX PHARMACEUTICAL financial statements.
Like other stocks, VRTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VERTEX PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VERTEX PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VERTEX PHARMACEUTICAL stock shows the buy signal. See more of VERTEX PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.